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1. Introduction 
Several groups have now shown that liposome- 
entrapped orally administered insulin can reduce blood 
glucose levels in diabetic rats [l-3]. However, there 
is some uncertainty over the extent to which lipo- 
somes remain intact and protect their contents in the 
gastrointestinal tract [2-91. The reported absorption 
ofintact liposomes [2] in vivo has not been confirmed 
[6]. Furthermore, while no significant uptake of lipo- 
some-entrapped material by everted rat gut sacs in 
vitro, was shown in [lo], it was in [ 1 l] that the up- 
take of non-degradable polyvinyl-pyrrolidone could 
be enhanced in vitro by liposome-entrapment. 
It has been shown [ 121 that both adult and neo- 
natal rat gut sacs can absorb the enzyme horseradish 
peroxidase (HRP) in vitro and the presence of the 
enzyme in the serosal fluid can be measured enzy- 
matically. In [8], only liposomes composed of di- 
stearoylphosphatidylcholine and cholesterol showed 
promise as protective carriers for oral use because 
they retained the majority of an entrapped macro- 
molecule in the presence of extremes of pH, bile salts 
and pancreatic lipase. This study compares the quan- 
tity of HRP present in the serosal fluid of everted rat 
gut sacs cultured in vitro with free HRP or with HRP 
entrapped within these ‘stable’ liposomes. The results 
show that distearoylphosphatidylcholine/cholesterol 
liposomes containing HRP can cross the gut wall and 
can increase the quantity of enzymatically active 
HRP that reaches the serosal fluid. 
2. Materials and methods 
2 .I. Preparation of ‘2sI-labelled HRP 
HRP (type II, EC 1 .l 1 .1.7., Sigma) was labelled 
with “‘1 by the chloramine T method [ 131 and the 
resulting solution was then dialysed (72 h at 4°C) in 
visking tubing against 10 changes of 1% (v/v) NaCl. 
Low Mr reaction products and any remaining chlo- 
ramine T or free iodide were removed by Sephadex 
G-l SO chromatography. The specific activity of the 
HRP so obtained was 0.01 mCi/mg. The enzymatic 
activity of the HRP was not altered by the iodination 
procedure. Of the total radioactivity 98% was precipi- 
tated with 10% phosphotungstic acid (Sigma). 
2.2. Liposome preparation 
L-cll-Distearoylphosphatidylcholine (Sigma) (27 mg) 
and 3.8 mg cholesterol (pure, i(och-Light Labs.) in 
15 ml chloroform were rotary evaporated under nitro- 
gen at 58°C and the lipid film was resuspended at 58”C, 
by hand agitation, with 2.5 ml 10 mM phosphate- 
buffered saline (PH 7 .O) containing 150 mg cold HRP 
with or without 5.0 HCi ‘251-labelled HRP. Free HRP 
was removed by centrifuging the preparation at 
10’ X g (10 min, 2O’C) removing the supernatant and 
resuspending the pellet in fresh buffer. This process 
was repeated 3 times. It was calculated from radioactiv- 
ity measurements that the final liposome prepara- 
tions contained 54.0 + 4.0 I.cg HRP/mg lipid (mean 
+ SE 8 preps.). Separate preparations of liposomes 
were pooled, centrifuged and resuspended in buffer. 
This final preparation was then diluted to give the 
various concentrations of liposomes required. In this 
way the lipid:HRP ratio remained constant over the 
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range of liposome concentrations used. The enzyme 
activity of HRP and the percentage of the total radio- 
activity that could be precipitated by phosphotungstic 
acid were unchanged by the liposome preparation 
procedure. ‘Empty’ liposomes were prepared by the 
above method but in the absence of unlabelled or 
12’ I-labelled HRP. 
2.3. Enzyme assay 
HRP was measured by a modification of the o-dian- 
isidine method [ 141 proposed in [IS] using 4-hydrox- 
yphenylacetic acid (4-HPAA, Sigma) as fluorogen. 
The reaction mixture contained 1 ml H2 O2 (0.3%, 
V/V), 0.8 ml 4-HPAA (1.522 mg in 10 ml methanol) 
and 98.2 ml 0.05 M phosphate buffer (pH 6.0). Dilu- 
tions of samples and standards were made in Tc 199 
medium (Wellcome). A 0.1 ml sample of test solution 
was mixed with 2.9 ml of reaction mixture and al- 
lowed to stand for 10 min at room temperature. The 
reaction was stopped with 0.6 ml 3.5 M K2C0a and 
fluorescence was determined in a Perkin-Elmer fluo- 
rime ter using an excitation wavelength of 3 19 nm and 
an emission wavelength of 4 10 nm. 
2.4. Liposomal latency 
Aliquots of liposomes containing both unlabelled 
and ‘251-labelled HRP were counted for total radioac- 
tivity and the total HRP content was calculated on 
the basis of an entrapment of 54 pg HRP/mg lipid. 
The percentage of the total radioactivity and HRp 
content that was present in a 10’ X g (10 mm) super- 
natant was determined by y counting and fluorimetry 
both before and after incubation of liposomes with 
Triton X-100 (1.25%, v/v) at 58°C for 30 min. The 
difference between the two sets of values represents 
the release of radioactivity and enzyme activity due 
to treatment of the liposomes with Triton X-100. The 
enzyme activity of HRP was shown in control experi- 
ments to be unaffected by incubation with Triton 
X-100 (1.25% v/v) at 58°C or by the presence of 
2.78 mg lipid/ml in the form of liposomes. 
2.5. Everted gut sac culture 
The preparation and method of culture of everted 
sacs of adult rat intestine has been described [ 111. 
Gut sacs were cultured with either: (a) free unlabelled 
at 37.5,75.0 and 150.0 pg/ml; (b) free unlabelled 
HRP at 37.5,75.0 and 150.0 pg/ml in the presence of 
‘empty’ liposomes at 0.695, 1.39 and 2.78 mg lipid/ml 
respectively; or (c) 37.5, 75 .O and 150.0 pg unlabel- 
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led HRP/ml entrapped in liposomes at 0.695, 1.39 
and 2.78 mg lipid/ml, respectively. 
After 2 h culture the serosal fluid from each sac 
was collected and the quantity of enzymatically active 
HRP present was determined fluorometrically both 
before and after incubation with 1.25% (v/v) Triton 
X-100 for 30 min at 58°C. The protein content of the 
gut sac tissue was determined as in [ 161. The quantity 
of enzymatically active HRP in the serosal fluid was 
calculated as ng HRP/mg gut sac tissue protein. 
3. Results and discussion 
Assuming an original entrapment of 54 pg HRP/mg 
lipid, fluorometric assay of enzymatically active HRP 
showed that treatments of liposomes with Triton 
X-100 released 49.3 f 0.8% (mean f SE 16 expt) of 
the entrapped enzyme. The extent of the release was 
confirmed by y counting which showed that the same 
samples released 48.6 + 1 .O% (mean + SE 16 expt) of 
their entrapped radioactivity. A 61% release of HRP 
following detergent treatment of liposomes was 
reported in [ 171. The total quantity of HRP present 
in a solution containing free and liposome-entrapped 
HRP can be calculated thus: 
Total HRP = [ lOO(QT - Qr;)/49.3] + QP 
where QF and QT are the quantities of HRP measured 
before and after treatment with Triton X-100 respec- 
tively. 
Table 1 shows that active HRP can be detected 
fluorometrically in the serosal fluid of gut sacs cul- 
tured with free enzyme and the quantity present 
increases with the substrate concentration. The pres- 
ence of ‘empty’ liposomes in the culture medium con- 
taining free HRP had no effect on the quantity of 
enzymatically active HRP that reached the serosal 
fluid. Table 1 also shows that Triton X-100 did not 
affect the fluorometric assay of enzymatically active 
HRP. Only a small quantity of active HRP could be 
detected in the serosal fluid of sacs cultured with lip- 
osome-entrapped HRP, unless the serosal fluid was 
treated with Triton X-100 (table 1). Assuming the 
Triton X-100 released 49.3%of the entrapped enzyme, 
the total HRP content of the serosal fluid was calcu- 
lated using the formula stated earlier. The corrected 
values (table 1) suggest hat the majority (95-98%) 
of the HRP present in the serosal fluid was entrapped 
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Table 1 
Comparison of the quantity of HRP present in the serosal fluid of gut sacs cultured for 2 h with free or Iiposomecntrapped RRP 
HRP 
@/ml) 
Liposomes 
(mg lipid/ml) 
ng HRP/mg tissue protein 
Before Triton After Triton Corrected 
Free HRP 
Free HRP + 
‘empty’ liposomes 
LipW?me- 
entrapped HRP 
37.5 - 1.16 f 0.07 
75.0 - 2.33 1: 0.12 
150.0a 5.64 * 0.20 
37.5 0.695 1.09 f 0.04 
75.0 1.390 2.29 r 0.07 
150.0 2.780 2.29 I 0.07 
37.5 0.695 0.16 f 0.02 
75.0 1.390 0.26 i 0.01 
150.0” 2.780 0.57 + 0.03 
1.14 f 0.06 - 
2.34 + 0.14 - 
5.60 + 0.18 
1.11 * 0.05 
2.30 + 0.08 _I 
2.30 t 0.08 
3.79 t: 0.12 7.52 f 0.24 
4.89 + 0.13 9.65 t 0.26 
5.78 f 0.22 11.14 f 0.45 
The quantity of enzymatically active HRP present in the serosal fluid was determined fluorometrically both before and after 
incubation with Triton X-100 (1.25% (v/v), 30min, 58’C). Eachvalue represents the mean f SE 8 expt (a 12expt). The corrected 
value is derived from the fact that Triton X-100 releases only 49.3% of the entrapped enzyme (see text) 
within liposomes. These liposomes had presumably Iesterol liposomes can cross the intestine wall and 
crossed the gut wall in a relatively intact form with- increase the quantity of a degradable macromolecule 
out fusing with lysosomes. The composition of the that reaches the serosal fluid in vitro. Given that these 
liposomes would favour endocytosis rather than mem- liposomes would probably protect their contents 
brane fusion since at 37°C d~S~earoyl~hos~hatidylcho- from intr~uminal digestion in vivo [gf , they appear 
line is we11 below its transition temperature of 58°C to have the quahties required of a protective carrier 
1181. for the oral administratian of therapeutic agents. 
Table 1 shows that entrapment of HRP within lipo- 
someS can increase the quantity of enzymaticahy active 
HRP that reaches the serosal fluid by up to 66fold. 
However, the extent of the increase falls from 6.6 to 
4.1 to 1.99-fold as the medium concentration of lipo- 
somes is raised from 0.695 to 1.39 to 2.78 mg lipid/ml, 
This suggests hat the uptake of liposome-entrapped 
HRP involves an adsorptive component which gradu- 
ally becomes aturated as the liposome concentration 
is raised [19]. The increased uptake ofliposome- 
entrapped HRP was not due to disruption of the tips- 
somes in the medium and re-association f the IIRP 
with the lipid as empty liposomes had no effect on 
the uptake of free HRP (table 1). Entrapment of non- 
degradable ’s I-labelled ~ol~viilyl~~rrolidone in lipo- 
somes only increaSed the quantity of macromolecule 
that reached the serosal fluid by 2-fold f I lf, even 
though the liposome concentration was considerably 
lower than here. This is probably because free HRP is 
susceptible to degradation by both brush border and 
in~racelI~laf enzymes 1201, while liposome~ntrap~~d 
HRP is protected. This protection from enzymic 
degradation would not be apparent when using a non- 
degradable macromolecule. 
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